3.32
                                            
            Scisparc Ltd stock is traded at $3.32, with a volume of 38,373.
            It is up +2.15% in the last 24 hours and down -30.11% over the past month.
            SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
        
        See More
    Previous Close:
              $3.25
            Open:
              $3.21
            24h Volume:
                38,373
            Relative Volume:
              0.01
            Market Cap:
                $1.77M
            Revenue:
              $1.31M
            Net Income/Loss:
              $-7.47M
            P/E Ratio:
              -0.4604
            EPS:
                -7.2117
            Net Cash Flow:
                $-5.11M
            1W Performance:
              -12.40%
            1M Performance:
              -30.11%
            6M Performance:
                +1,049%
            1Y Performance:
              +1,324%
            Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SPRC
                            
                             
                        Scisparc Ltd 
                           | 
                    3.32 | 5.27M | 1.31M | -7.47M | -5.11M | -7.2117 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Scisparc Ltd Stock (SPRC) Latest News
How SciSparc Ltd. stock performs in interest rate cyclesJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Heatmap analysis for SciSparc Ltd. and competitorsJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Is SciSparc Ltd. stock entering bullish territory2025 Big Picture & Low Risk Entry Point Tips - newser.com
Will SciSparc Ltd. bounce back from current supportQuarterly Portfolio Report & Real-Time Market Sentiment Reports - newser.com
Live market analysis of SciSparc Ltd.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Tools to monitor SciSparc Ltd. recovery probabilityVolume Spike & Weekly High Momentum Picks - newser.com
Is SciSparc Ltd. stock a top momentum playJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Scisparc Ltd (SPRC) Stock Price, News & Analyst Forecast - eToro
N2OFF (NASDAQ: NITO) closes MitoCareX merger; issues 40% of fully diluted shares - Stock Titan
Is SciSparc Ltd. stock in correction or buying zoneWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
SciSparc’s SCI-110 Study: A Potential Game-Changer for Tourette Syndrome - TipRanks
SciSparc gets Nasdaq extension to regain compliance - MSN
SciSparc Ltd. stock retracement – recovery analysis2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
What dividend safety score for SciSparc Ltd. stockJuly 2025 Closing Moves & Fast Moving Stock Watchlists - fcp.pa.gov.br
Is SciSparc Ltd. stock attractive for passive investorsJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará
SciSparc’s Promising Clinical Study on SCI-210 for Autism Spectrum Disorder - TipRanks
SciSparc Completes Acquisition of Neurothera Labs Inc. - TipRanks
Form 6-K: SciSparc finalizes TSXV deal, pharma portfolio moved - Stock Titan
SciSparc Completes Sale of MitoCareX to N2OFF, Enhancing Cancer Drug Discovery - MSN
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):